Benjamin Schwarz
Seminars
Thursday 2nd October 2025
Strategic Selection of iPSC Starting Lines to Enhance Safety, Consistency & Manufacturability
12:00 pm
- Evaluating donor variability and genomic stability
- Predicting differentiation potential and therapeutic performance of cell lines
Wednesday 1st October 2025
Panel Discussion: Understanding the Current Barriers to Achieving Closed System Automated Manufacturing
2:00 pm
- Discussing key hurdles such as cost, complexity of processes, and regulatory challenges when adopting new instruments
- What are some opportunities in iPSC manufacturing processes where automation can be introduced?
Tuesday 30th September 2025
Balancing Quality, Consistency & Scalability of Starting Cell Lines through Strategic Selection
Choosing the right iPSC starting line is fundamental to influencing safety, efficacy, and manufacturability. Key factors such as donor selection, genomic stability, and differentiation potential must be carefully evaluated alongside evolving regulatory expectations. This session will explore best practices for optimizing cell line selection, balancing standardization with therapy-specific requirements.
